Collagen peptides in osteogenesis imperfecta, idiopathic juvenile osteoporosis and Ehlers-Danlos syndrome

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 6, 1996, Pages 688-691

  Proszynska K ^a   Wieczorek, E ^a   Olszaniecka, M ^a   Lorenc, R S ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PEPTIDE; PROCOLLAGEN;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CHILD; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; EHLERS DANLOS SYNDROME; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; PEPTIDE ANALYSIS; PREPUBERTY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PUBERTY;

EID: 0029831313     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14126.x     Document Type: Article

References (13)

1. Morike M, Brenner RE, Bushart GB, Teller WM, Vetter U. Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients. Biochem J 1992;286:73-7
2. Baron R, Gertner JM, Lang R, Vignery A. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda. Pediatr Res 1983;17:204-7
3. Fedarko NS, Moerike M, Brenner R, Robey PG, Vetter U. Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 1992;7:921-30
4. Brenner RE, Vetter U, Nerlich A, Worsdorfer O, Teller WM, Muller PK. Osteogenesis imperfecta: insufficient collagen synthesis in early childhood as evidenced by analysis of compact bone and fibroblast cultures. Eur J Clin Invest 1989;19:159-66
5. Rowe DW, Shapiro JR, Poirier M, Schlesinger S. Diminished type I collagen synthesis and reduced alpha 1 (I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta. J Clin Invest 1985; 76:604-11
6. Fraser J, Lancaster GA, Serever CR. Secreted collagen ratios in normal human and osteogenesis imperfecta skin fibroblasts. Connect Tissue 1983;11:57-67
7. Brenner RE, Schiller B, Vetter U, Ittner J, Teller WM. Serum concentrations of procollagen I C-terminal propeptide, osteocalcin and insulin-like growth factor-I in patients with non-lethal osteogenesis imperfecta. Acta Paediatr 1993;82:764-7
8. Stolle CA, Pyeritz RE, Myers JC, Prockop DJ. Synthesis of an altered type III procollagen in a patient with type IV Ehlers Danlos syndrome. J Biol Chem 1985;260:1937-44
9. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16:101-16
10. McKusick VA. Catalog of autosomal dominant and recessives autosomal and X-linked diseases. 7th ed., Baltimore: Johns Hopkins University Press, 1986:215-7
11. Trivedi P, Risteli J, Risteli L, Hindmarsh PC, Brook CG, Mowat AP. Serum concentrations of the type I and III procollagen peptides as biochemical markers of growth velocity in healthy infants and children with growth disorders. Pediatr Res 1991;30:276-80
12. Lorenc RS, Prószyńska K, Wieczorek E, Olszaniecka M, Matusik H, Talajko A. Diagnostics and monitoring of osteogenesis imperfecta. XIIIth Meeting of the Federation of European Connective Tissue Societies; 1992; Davos, Switzerland: 12-17. VII
13. Brenner RE, Vetter U, Bollen A-M, Morike M, Eyre DR. Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta. J Bone Miner Res 1994;9:993-97